Johns Hopkins Community Physicians
6
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
33.3%
2 terminated/withdrawn out of 6 trials
60.0%
-26.5% vs industry average
0%
0 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome
Role: collaborator
SHARE: Sharing Healthcare Wishes in Primary Care
Role: collaborator
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Role: collaborator
Involving Family to Improve Communication in Primary Care
Role: collaborator
A Comprehensive Disease Management Program for Medically-Complex Substance Users
Role: collaborator
Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities
Role: collaborator
All 6 trials loaded